NEFROSAVE Tablet is a Patented combination medicine that helps to delay the progression of Chronic kidney disease associated with diabetes and hypertension.
For more information Visit www.nefrosave.com
Kidney disease can be broadly classified into two types : Chronic kidney disease (CKD) and Acute Kidney injury (AKI). Both if untreated can lead to permanent kidney damage. Long term diabetes and hypertension can lead to CKD.
Each film coated tablet contains:
Accetylcysteine USP – 150mg
Taurine USP – 500mg
Nefrosave is beneficial in reduction of Microalbuminuria associated with CKD Stages 1-3.
Nefrosave reduces Microalbuminuria & TGF β levels by 50%*
*Ind.J.of Neph.2008
The recommended dose of Nefrosave is 1 Tablet twice daily after food or as directed by the Physician.
Fourrts Global
SFA Login
